Montamat-Sicotte et al. [36] found that Heat Shock Protein 90 inhibitors decrease AID protein levels and reduced disease severity in a mouse model of acute B-cell lymphoblastic leukemia in which AID accelerates disease progression. Here, AICDA is linked to B-cell acute lymphoblastic leukemia.